Skip to main content
Medicare intends to limit payment for controversial Alzheimer’s drug
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Medicare intends to limit payment for controversial Alzheimer’s drug
User login
Username
Password
Reset your password
Concept
Lead
score
Alzheimer Disease
1
1
Medicare
0
0.99
Biologic Therapy
0
0.57
Aducanumab
0
0.98
Food and Drug Administration (FDA)
0
0.34
Clinical Research
0
0.14
Monoclonal Antibody
0
0.14
Amyloid Plaque
0
0.05
Biomedical Technology
0
0.05
Cancer
0
0.05
Central Nervous System
0
0.05
Cognition
0
0.05
Geriatrics
0
0.05
Grant
0
0.05
Medicaid
0
0.05
Off-Label Use
0
0.05
Specialty
Lead
score
Neurology & Neurosurgery
1
1
Internal Medicine
0
0.8
Psychiatry
0
0.9